![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
GS Simon and WL Dewey
The antinociceptive potency of morphine as determined by the tail-flick test was significantly decreased in streptozotocin (STZ)-induced diabetic mice and mice pretreated with hypertonic dextrose or fructose. STZ-induced diabetic rats and spontaneously diabetic mice were also significantly less sensitive to the antinociceptive effects of morphine in the tail-flick test. Hypoglycemic mice were significantly more sensitive to morphine. Insulin-reversal of dextrose- and STZ-induced diabetic hyperglycemia returned sensitivity to morphine-induced antinociception to control values. Pretreatment with hypertonic 3-O- methylglucose (a nonmetabolizable sugar) had no effect on morphine potency. The ability of morphine to inhibit phenylquinone-induced writhing was attenuated in STZ-induced diabetic mice. Mice receiving various pretreatments (STZ-induced diabetes, STZ-induced diabetes plus insulin, dextrose, fasting or fasting plus insulin) were subjected to analyses of their serum glucose levels, serum insulin levels and brain glucose lvels. From these data, it appeared that only hyper- or hypoglycemia correlated (inversely) with changes in the potency of morphine. It is hypothesized that the diabetes-induced hyperglycemia is responsible for selectively affecting the potency of morphine.
This article has been cited by other articles:
|
|
 |
|
  Y. Xing, J. Sonner, M. J. Laster, W. Abaigar, V. B. Caraiscos, B. Orser, and E. I Eger II Insulin Decreases Isoflurane Minimum Alveolar Anesthetic Concentration in Rats Independently of an Effect on the Spinal Cord Anesth. Analg., June 1, 2004; 98(6): 1712 - 1717. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tasatargil and G. Sadan Reduction in [D-Ala2, NMePhe4, Gly-ol5]Enkephalin-Induced Peripheral Antinociception in Diabetic Rats: The Role of the L-Arginine/Nitric Oxide/Cyclic Guanosine Monophosphate Pathway Anesth. Analg., January 1, 2004; 98(1): 185 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Witt, J. D. Huber, R. D. Egleton, and T. P. Davis Insulin Enhancement of Opioid Peptide Transport across the Blood-Brain Barrier and Assessment of Analgesic Effect J. Pharmacol. Exp. Ther., December 1, 2000; 295(3): 972 - 978. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. J. Rady, B. B. Holmes, P. S. Portoghese, and J. M. Fujimoto Morphine Tolerance in Mice Changes Response of Heroin from {micro} to {delta} Opioid Receptors Experimental Biology and Medicine, June 1, 2000; 224(2): 93 - 101. [Abstract] [Full Text]
|
|
|
|
|
|
M. Ohsawa, H. Nagase, and J. Kamei Role of Intracellular Calcium in Modification of Mu and Delta Opioid Receptor-Mediated Antinociception by Diabetes in Mice J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 780 - 787. [Abstract] [Full Text]
|
|
|
|
|
|
C. Courteix, P. Bourget, F. Caussade, M. Bardin, F. Coudore, J. Fialip, and A. Eschalier Is the Reduced Efficacy of Morphine in Diabetic Rats Caused by Alterations of Opiate Receptors or of Morphine Pharmacokinetics? J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 63 - 70. [Abstract] [Full Text]
|
|
|
|
|
|
N. Takeshita and I. Yamaguchi Insulin Attenuates Formalin-Induced Nociceptive Response in Mice through a Mechanism that Is Deranged by Diabetes Mellitus J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 315 - 321. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
